4

PRIMARY DOCUMENT

Company: ENDONOVO THERAPEUTICS, INC.
Filed: June 28, 2019
Period of Report: June 18, 2019
Accession Number: 0001645470-19-000040

View Document ↗ View on SEC.gov ↗